The Pancreum closed loop (automated insulin + CGM + glucagon) system that won a Grand Prize in the DiabetesMine Design Challenge this year may look like a pipe dream, but designer Gil DePaula assures us it is “visionary but real.”
Have a look at the video, below, and also Gil’s company website.
“The glucagon part is definitely a futuristic concept — because there’s no predicate device for glucagon delivery with the FDA, so that’s a…
Read more »
We recently mentioned a product called DiaPort from Roche, invented way back in 1998, which insulin researchers have been talking about lately as a possible alternative to the implantable insulin pump! Say what? you may ask. What makes this injection port with internal tubing so powerful? Especially when there’s a newer product called iPort that seems to do the same thing, possibly more elegantly?
Well, the DiaPort must be surgically implanted, and its advantage is…
Read more »
John Steuart is Managing Director at Claremont Creek Ventures, a VC firm in Silicon Valley that invests in information technology and life sciences companies. Their tagline is: “We seek passionate entrepreneurs with disruptive technologies who want to change the world.”
We’re delighted to have John join us again this year as a judge in the DiabetesMine Design Challenge. In case you missed this morning’s bulletin: CONTEST VOTING CLOSES TODAY AT 6pm PST, so take 2…
Read more »
Last week, the New York Chapter of the Juvenile Diabetes Research Foundation hosted their annual research briefing. Many chapters around the country host similar research briefings, and I was excited to find out that our local meeting would feature Dr. Sanjoy Dutta, Director of Glucose Control Therapies within the Treatment Therapies Program.
I want to note that although there’s been a lot of controversy surrounding the addition of treatment goals to JDRF’s mission, I whole-heatedly…
Read more »
